Holen Sie sich die Stockscreener-App
81.89
0.00%
0.00
Handel nachbörslich:
81.89
Schlusskurs vom Vortag:
$81.89
Offen:
$80.97
24-Stunden-Volumen:
2,900
Relative Volume:
0.42
Marktkapitalisierung:
$281.93M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.48%
1M Leistung:
-1.43%
6M Leistung:
+26.08%
1J Leistung:
+22.46%
1-Tages-Spanne:
$80.97
$81.89
1-Wochen-Bereich:
$80.97
$83.57
52-Wochen-Spanne:
$54.52
$85.73
Invesco Biotechnology Genome Etf Stock (PBE) Company Profile
Firmenname
Invesco Biotechnology Genome Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare PBE vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PBE
Invesco Biotechnology Genome Etf
|
81.89 | 281.93M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
341.47 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
691.96 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
695.05 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
278.13 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
613.11 | 124.43B | 0 | 0 | 0 | 0.00 |
Invesco Biotechnology Genome Etf Aktie (PBE) Neueste Nachrichten
Top ETFs Tracking CRISPR Gene Editing for 2026 - The Motley Fool
Is Invesco Biotechnology & Genome ETF (PBE) a strong ETF right now? - MSN
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Yahoo Finance
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - sharewise.com
(PBE) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Responsive Playbooks and the PBE Inflection - Stock Traders Daily
Short Interest in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Expands By 23.3% - Defense World
Bank of Ireland Group (LON:BIRG) Reaches New 52-Week High – What’s Next? - Defense World
Comprehensive Money Management Services LLC Reduces Position in Global X Genomics & Biotechnology ETF $GNOM - Defense World
Understanding the Setup: (PBE) and Scalable Risk - Stock Traders Daily
Genome ETF stock stage a strong rebound this quarterMarket Risk Report & Free Expert Approved Momentum Trade Ideas - Улправда
Invesco Biotechnology & Genome ETF (NY: PBE - FinancialContent
PRN_FinancialWrapper | PR NewswireInvesco Biotechnology & Genome ETF (NYSE:PBE) Detailed Stock Data - FinancialContent
Invesco Exchange-Traded Fund TrustInvesco Biotechnology & Genome ETF Reports Earnings Results for the Half Year Ended October 31, 2025 - MarketScreener
Institution Moves: Can Invesco Biotechnology Genome ETF stock sustain breakout momentumShare Buyback & Fast Gain Swing Trade Alerts - moha.gov.vn
Genome ETF stock among top earnings playsQuarterly Earnings Report & Proven Capital Preservation Tips - Улправда
Genome ETF stock deliver double digit returnsQuarterly Portfolio Report & AI Based Trade Execution Alerts - Улправда
Top Canadian Genetics Stocks of 2026 - The Motley Fool Canada
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - Business Wire
Inside the Recent Strength in Biotech ETFs - TradingView
Genome ETF stock announce special dividendWeekly Trade Summary & Stepwise Entry and Exit Trade Signals - newser.com
Genome ETF stock considered safe havenJuly 2025 Setups & Stepwise Trade Signal Implementation - newser.com
2 ETFs to Watch for Outsized Volume on Biotechnology Stocks - TradingView
Invesco Biotechnology & Genome ETF declares quarterly distribution of $0.2341 - MSN
Genome ETF stock compared to rivalsJuly 2025 News Drivers & Precise Swing Trade Alerts - Trung tâm Dự báo KTTV quốc gia
Genome ETF stockChart Signals & Fast Exit and Entry Trade Guides - newser.com
Wealth Enhancement Advisory Services LLC Sells 2,491 Shares of Invesco Biotechnology & Genome ETF $PBE - Defense World
Genome ETF stock benefit from mergersTrade Risk Summary & Consistent Return Strategy Ideas - newser.com
The Best Biotech ETFs to Buy - Kiplinger
Genome ETF stock deliver strong annual returnsJuly 2025 Drop Watch & Weekly Watchlist for Consistent Profits - newser.com
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk - Benzinga
Signet Financial Management LLC Grows Position in Invesco Biotechnology & Genome ETF $PBE - Defense World
Invesco Biotechnology & Genome ETF $PBE Position Decreased by HighTower Advisors LLC - Defense World
Finanzdaten der Invesco Biotechnology Genome Etf-Aktie (PBE)
Es liegen keine Finanzdaten für Invesco Biotechnology Genome Etf (PBE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.49%
0.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):